Hamlet BioPharma AB

Hamlet BioPharma operates in the pharmaceutical industry. The company conducts drug development based on a tumor-killing protein-lipid complex, formed from two natural and harmless molecules found in breast milk. The development aims to produce preparations that will primarily be used for the treatment and prevention of cancer diseases. Hamlet BioPharma was founded in 2015 and is headquartered in Lund.

Quotes for Hamlet BioPharma AB

Right Now

+/-
-0.01
%
−0,16%
Latest
6.08
High
6.09
Low
5.67
Volume
108 496
Turnover (SEK)
633 792
Market Value (MSEK)
915,4
Time (Latest trade)
2026-09-23 17:24

Board

CEO

  • Jakob Testad

Chairperson of the Board

  • Catharina Svanborg

Board

  • Bill Hansson
  • Henrik Sundin
  • Magnus Nylen
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    This is HAMLET - The movie

    Hamlet Pharma - Life Sciencedagen

    Intervju med styrelseordförande Catharina Svanborg

    Interview with Catharina Svanborg Chairman of the Board/Founder

    Insider trading

    *Powered by Modular Finance

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2026-11-13 Interim Report 2027-Q1

    • 2026-11-20 Annual General Meeting 2026

    Annual reports, prospectus etc.